Experimental Breast Cancer Drug Holds Promise in Combination Therapy...
St. Jude Children’s Research Hospital researchers have identified a promising new triple-drug combination therapy that exploits DNA repair problem in Ewing sarcoma tumors; clinical trials expected to...(PRWeb October 23, 2014)Read the full story at http://www.prweb.com/releases/2014/10/prweb12273480.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news
More News: Bone Cancers | Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Ewing's Sarcoma | Gastroschisis Repair | Hospitals | Pharmaceuticals | Sarcomas